Lifeloc Technologies Reports $2.47 Million Net Loss Despite 6% Revenue Growth in 2025

Lifeloc Technologies, Inc. reported a net loss of $2.47 million for the fiscal year ending December 31, 2025, compared to a loss of $1.05 million in 2024. The company's total revenues increased by 6% to $9.03 million, driven primarily by new customer acquisitions and expansion within existing accounts. Product sales rose to $8.96 million from $8.47 million in the previous year, while royalties and rental income contributed an additional $68,266. Despite the revenue growth, the company faced increased costs, particularly in raw materials and labor, which impacted profitability.

The company’s gross profit for 2025 was $3.64 million, maintaining a gross profit margin of 40%, consistent with the previous year. Research and development expenses remained high at $2.15 million, reflecting ongoing investments in the development of the SpinDetect™ platform, which is expected to launch in 2026. Sales and marketing expenses were stable at $1.33 million, while general and administrative expenses increased by 11% to $1.39 million, largely due to public company and legal expenses.

Operationally, Lifeloc Technologies has focused on expanding its product offerings and customer base. The company has shifted its strategy to emphasize the commercialization of new sensing and measurement products, particularly the SpinDetect™ technology, which aims to provide rapid, on-site drug testing. The company anticipates that the introduction of this product will enhance its market position and drive future revenue growth. As of December 31, 2025, Lifeloc employed 35 full-time and 3 part-time employees, with no significant changes in headcount reported.

In terms of financial health, Lifeloc's cash and cash equivalents stood at $746,001, with trade accounts receivable at $772,380. The company’s current liabilities totaled $836,870, indicating a tight liquidity position. Lifeloc has incurred significant debt, including subordinated debentures totaling $681,343, which require ongoing interest payments. The company has indicated that it may need to seek additional financing if the commercialization of SpinDetect™ takes longer than expected or if revenues do not grow as anticipated.

Looking ahead, Lifeloc Technologies remains optimistic about its growth prospects, particularly with the anticipated launch of SpinDetect™. The company plans to continue investing in research and development while managing costs effectively. However, it acknowledges the potential for ongoing revenue fluctuations due to the unpredictable nature of customer orders and market conditions. The management's outlook emphasizes the importance of maintaining operational efficiency and exploring new market opportunities to achieve profitability in the coming years.